Evidence map›Paper›PMID 41034898›Full record

ArticleBMC public health2025

A cluster of severe fever with thrombocytopenia syndrome with household and nosocomial transmission in Zhejiang Province, China, 2023.

Ying Liu, Yan Ma, Liangyue Chen, Xuguang Shi, Yirong Fang, Tianqi Li, Jinna Wang, Hao Yan, Xiaowei Song, Guoqin Jiang and 3 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ying Liu *Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Yan Ma *Shaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang Province, China.
Liangyue ChenXinchang Center for Disease Control and Prevention, Shaoxing, Zhejiang Province, China.
Xuguang ShiKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Yirong FangShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang Province, China.
Tianqi LiKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Jinna WangKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Hao YanKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Xiaowei SongXinchang Center for Disease Control and Prevention, Shaoxing, Zhejiang Province, China.
Guoqin JiangShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang Province, China.
Gaofeng CaiKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China. gfcai@cdc.zj.cn.
Jianmin JiangKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China. jmjiang@cdc.zj.cn.
Jimin SunKey Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China. jmsun@cdc.zj.cn.

Funding

Key Program of Health Commission of Zhejiang Province/Science Foundation of National Health Commission WKJ-ZJ-2523Key projects of the National Natural Science Foundation of China U23A20496the Key Grants of Department of Science and Technology of Zhejiang Province 2024C03216the Key Grants of Department of Science and Technology of Zhejiang Province 2025C02186the National Key Research and Development Project by the Ministry of Science and the Technology of China 2023YFC2308705Zhejiang Provincial Science and Technology Program for Disease Prevention and Control 2025JK186
6 · The paper itself

Abstract

backgroundSevere fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by the SFTS virus (SFTSV). It is primarily transmitted by tick bites, and person-to-person transmission can occur through direct contact with the blood or blood-contaminated secretions of patients. We analyzed and discussed the transmission routes of a cluster of SFTS involving both household and nosocomial transmission, providing foundational data for the prevention and control of SFTS.

methodsWe investigated a cluster of SFTS cases in Zhejiang Province, China, in April 2023. Epidemiological, clinical, and entomological data were collected and analyzed. Genetic sequencing was used to confirm SFTSV infection and identify the source of the outbreak.

resultsEight cases were identified, including one index case and seven secondary infections among the family members and healthcare workers (HCWs). The index patient, an 82-year-old female, likely contracted SFTSV from tick bites in her tea plantation. Direct contact with the patient’s blood led to secondary infections. 7 of the 12 individuals with direct blood contact developed SFTS, which was significantly different from that of individuals without direct blood contact (P = 0.01). Genetic analysis confirmed high homology between SFTSV sequences from patients and ticks.

conclusionsWe demonstrated that the transmission routes of this SFTS cluster originated from a fatally ill patient infected through tick bites, and subsequently spread to family members and healthcare workers via blood contact. Enhanced infection control measures and early diagnosis are crucial.

Indexed as

Cross InfectionFamily CharacteristicsSevere Fever with Thrombocytopenia SyndromeAdultAgedAged, 80 and overAnimalsChinaCluster AnalysisDisease OutbreaksFemaleHumansMaleMiddle AgedPhlebovirusHousehold transmissionNosocomial transmissionSevere fever with thrombocytopenia syndrome

Identifiers

PMID41034898
PMCPMC12486768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.